AllAnalyst Report
Morningstar•August 18, 2021
Morningstar•August 18, 2021Tilray Brands, Inc.: Tilray's Purchase of MedMen's Convertible Debt Gives It a Toehold Into U.S. THC at a Good Price
Summary
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market.
Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Actions
Download Full ReportRelated Reports
- Analyst Report: Roku, Inc.Apr 17, 2024 •
ROKU
- GME: Lowering target price to $8.00Apr 17, 2024 •
GME
- Analyst Report: Cronos Group Inc.Apr 15, 2024 •
CRON
- Analyst Report: NIO Inc.Apr 13, 2024 •
NIO
- Technical Assessment: Neutral in the Intermediate-TermApr 12, 2024 •
DKNG, DIS
Analyst Profile
Kristoffer Inton
DirectorKristoffer Inton is director of equity research, basic materials for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. He covers gold, aggregates and cement, and uranium companies.Before joining Morningstar in 2013, Inton was an investment banking associate for Guggenheim Securities in New York. Previously, he was an investment banking analyst for Merrill Lynch in Chicago and New York.Inton holds a bachelor’s degree in finance with high honors from the University of Illinois and a master’s degree in business administration with distinction from Northwestern University’s Kellogg School of Management.